IONS Stock Performance and Key Statistics

IONS has a current P/E ratio of -51.09

The IONS stock has a trailing twelve month price-to sales (P/S) ratio of 13.65 while its price-to-book (P/B) value is 21.19.

IONS's price-to-free-cashflow (P/FCF) ratio is -43.6, an indicator that is currently being trending upward.

Based on IONS's recent bid, its distance from 20 days simple moving average is -2.95%. It is -0.38% apart from 50 days simple moving average, and it is 32.58% apart from 200 days simple moving average.

The 52-week high for IONS is $86.74 which is -6.7% away from the current price level whereas the distance of that from the 52-week low of $23.95 stands at 237.91%.

The performance of IONS stock was not encouraging with most of its significant price indicators in red. Ionis Pharmaceuticals, Inc.(NASDAQ: IONS) shares have moved downward -5.29% or - $4.52 in the latest trading session and have lost -2% year-to-date (YTD). The stock has gained nearly 140.18% over the past year. After moving 6.07% over the trailing 3-month period, the stock is 86.59% higher in the 6-month period. Looking at its performance over the shorter term, it'slost -5.06% a week and 0.58% a month.

The current 14-day RSI for IONS stock is 45.7. Investors and traders alike rely on the relative strength index, or RSI, as an oscillating indicator. In terms of values, the RSI operates within a range ranging from 0 to 100. A rising RSI line indicates strength in the shares. As the RSI line falls, the opposite occurs. It is possible to examine different time periods when using the RSI indicator. Shorter time frames can cause the RSI to be more volatile. Most traders pay close attention to the marks between 30 and 70 on the RSI scale. When the stock price moves over 70, it is often considered to be an indicator of overbought conditions. Dropping below 30 indicates oversold territory. These levels are often used by traders to forecast stock price reversals.

ATR stands for Average True Range, which may be useful when traders or investors are assessing technical inventory. Currently, Ionis Pharmaceuticals, Inc. (IONS) has a 14-day ATR of 2.67.

After closing at $85.45 with 161.97M of its shares outstanding, the current enterprise value of IONS is roughly 7.24B.

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) is up 140.18% when it comes to the percentage price change over the past 52-weeks. The percentage price change came more than that of broader S&P 500 index that came at a rise of 10.91%. IONS stock price is also down -2% on its value in year-to-date trading.

The number outstanding shares of IONS is 161.97M, and of these 99.16% shares are freely available for trading. On average, IONS stock has traded 2.29M shares per day for the past 10 days. A total of 3.1M shares changed hands during the last trading session with the average session volume of 2.08M shares.